Jinhe Biotechnology(002688) 证券之星· Zheng Quan Zhi Xing·2025-05-15 10:21Core Viewpoint - The company has completed the repurchase and cancellation of 60,000 restricted stocks from one incentive object due to retirement, which represents 0.01% of the total share capital before the repurchase [1][7]. Summary by Relevant Sections Incentive Plan Details - The 2023 restricted stock incentive plan involved one incentive object, with a total of 60,000 shares repurchased at a price of 2.39 yuan per share, totaling 143,400 yuan [1][7]. - After the cancellation, the company's total share capital decreased from 771,694,398 shares to 771,634,398 shares [1][7]. Approval Procedures - The company has followed the necessary approval procedures for the 2023 restricted stock incentive plan, including independent opinions from the board and verification from the supervisory board [1][2][3]. Repurchase Reasons and Conditions - The repurchase was necessitated by the retirement of one incentive object, who no longer qualifies for the incentive plan, leading to the cancellation of their unvested shares [6][7]. - The repurchase price was adjusted to 2.39 yuan per share, in accordance with the company's regulations [6][7]. Impact on Company Structure - The repurchase of restricted stocks will not adversely affect the company's operational results or its compliance with listing conditions, and the stock incentive plan will continue to be executed as per regulations [8].